Cargando…
Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306204/ https://www.ncbi.nlm.nih.gov/pubmed/32579980 http://dx.doi.org/10.1016/j.jinf.2020.06.049 |
| _version_ | 1783548610116321280 |
|---|---|
| author | Daunt, Anna Perez-Guzman, Pablo N. Liew, Felicity Hauck, Katharina Costelloe, Ceire E. Thursz, Mark R. Cooke, Graham Nayagam, Shevanthi |
| author_facet | Daunt, Anna Perez-Guzman, Pablo N. Liew, Felicity Hauck, Katharina Costelloe, Ceire E. Thursz, Mark R. Cooke, Graham Nayagam, Shevanthi |
| author_sort | Daunt, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7306204 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73062042020-06-22 Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease Daunt, Anna Perez-Guzman, Pablo N. Liew, Felicity Hauck, Katharina Costelloe, Ceire E. Thursz, Mark R. Cooke, Graham Nayagam, Shevanthi J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2020-10 2020-06-21 /pmc/articles/PMC7306204/ /pubmed/32579980 http://dx.doi.org/10.1016/j.jinf.2020.06.049 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Daunt, Anna Perez-Guzman, Pablo N. Liew, Felicity Hauck, Katharina Costelloe, Ceire E. Thursz, Mark R. Cooke, Graham Nayagam, Shevanthi Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease |
| title | Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease |
| title_full | Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease |
| title_fullStr | Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease |
| title_full_unstemmed | Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease |
| title_short | Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease |
| title_sort | validity of the uk early access to medicines scheme criteria for remdesivir use in patients with covid-19 disease |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306204/ https://www.ncbi.nlm.nih.gov/pubmed/32579980 http://dx.doi.org/10.1016/j.jinf.2020.06.049 |
| work_keys_str_mv | AT dauntanna validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease AT perezguzmanpablon validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease AT liewfelicity validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease AT hauckkatharina validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease AT costelloeceiree validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease AT thurszmarkr validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease AT cookegraham validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease AT nayagamshevanthi validityoftheukearlyaccesstomedicinesschemecriteriaforremdesiviruseinpatientswithcovid19disease |